Concepedia

Publication | Closed Access

Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.

69

Citations

0

References

2006

Year

Pranab Das, David J. Moliterno, Richard Charnigo, Debabrata Mukherjee, Steven R. Steinhubl, Jeannie Sneed, David C. Booth, Khaled M. Ziada
PubMed

Abstract

A high rate of ischemic events was noted for ESRD patients, regardless of stent type. However, in ESRD patients undergoing coronary revascularization, DES use is effective in reducing 9-month TVR and the composite of death, MI and TVR.